Aalborg University Hospital is the largest hospital in the North Denmark Region, Denmark. It is also northern Jutland's largest employer, with approximately 6,500 employees. The hospital consists of Section South and North in Aalborg and Dronninglund Hospital.

During the past decade, Hæmatologisk afd. B Aalborg Sygehus Syd conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hæmatologisk afd. B Aalborg Sygehus Syd" are "Multiple Myeloma" (2 trials), "Antimetabolites, Antineoplastic" (1 trials), "Digestive System Diseases" (1 trials), "Digestive System Neoplasms" (1 trials) and "Endocrine Gland Neoplasms" (1 trials). Many other conditions were trialed in "Hæmatologisk afd. B Aalborg Sygehus Syd" in a lesser frequency.

Most popular intervention types in "Hæmatologisk afd. B Aalborg Sygehus Syd" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "pomalidomide" (2 trials), "Aspirin" (1 trials), "CC-5013" (1 trials), "Dexamethasone" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hæmatologisk afd. B Aalborg Sygehus Syd" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Hæmatologisk afd. B Aalborg Sygehus Syd". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hæmatologisk afd. B Aalborg Sygehus Syd, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hæmatologisk afd. B Aalborg Sygehus Syd, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".